Clinical Trials Directory

Trials / Unknown

UnknownNCT02458781

Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth

Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth: A Randomized, Double-Blind, Placebo-Controlled Trial Comparing Ciprofloxacin and Metronidazole

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
San Antonio Military Medical Center · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, double-blind, placebo-controlled study to evaluate the efficacy of ciprofloxacin versus metronidazole versus placebo in eradication of small intestinal bacterial overgrowth (SIBO).

Detailed description

Approximately 180 study subjects with SIBO identified by positive glucose hydrogen breath (GHB) testing who meet inclusive and exclusive criteria will be randomized to receive either ciprofloxacin 500mg by mouth twice daily, metronidazole 500mg by mouth twice daily, or placebo by mouth twice daily. Subjects will complete a baseline symptom questionnaire and be treated for 14 days. Response will be assessed at end of treatment. The Gastrointestinal Symptom Rating Scale (GSRS) and GHB testing will be performed at the end of treatment. Subjects with a negative GHB at the end of treatment are considered as cured, or treatment success. Patients with treatment success will be reassessed for long-term response to treatment or disease recurrence at 30 days, 4 months, and 9 months using GHB. Symptoms will also be re-assessed at the 30 day, 4 month, and 9 month intervals with GSRS-IBS symptom questionnaire done prior to GHB testing.

Conditions

Interventions

TypeNameDescription
DRUGMetronidazoleMetronidazole 500mg given twice daily for 14 days
DRUGCiprofloxacinCiprofloxacin 500mg given twice daily for 14 days
DRUGPlaceboPlacebo given twice daily for 14 days

Timeline

Start date
2015-01-01
Primary completion
2018-01-01
Completion
2018-06-01
First posted
2015-06-01
Last updated
2015-06-01

Source: ClinicalTrials.gov record NCT02458781. Inclusion in this directory is not an endorsement.